These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 31713494)
1. Polyphenolic Compounds and Gut Microbiome in Cardiovascular Diseases. McGrail L; Garelnabi M Curr Pharm Biotechnol; 2020; 21(7):578-586. PubMed ID: 31713494 [TBL] [Abstract][Full Text] [Related]
2. Role of Dietary Flavonoid Compounds in Driving Patterns of Microbial Community Assembly. Ivey KL; Chan AT; Izard J; Cassidy A; Rogers GB; Rimm EB mBio; 2019 Sep; 10(5):. PubMed ID: 31551328 [TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota Modulation and Anti-Inflammatory Properties of Dietary Polyphenols in IBD: New and Consolidated Perspectives. Santino A; Scarano A; De Santis S; De Benedictis M; Giovinazzo G; Chieppa M Curr Pharm Des; 2017; 23(16):2344-2351. PubMed ID: 28176667 [TBL] [Abstract][Full Text] [Related]
4. Dietary Polyphenols and Gut Microbiota Cross-Talk: Molecular and Therapeutic Perspectives for Cardiometabolic Disease: A Narrative Review. Cano R; Bermúdez V; Galban N; Garrido B; Santeliz R; Gotera MP; Duran P; Boscan A; Carbonell-Zabaleta AK; Durán-Agüero S; Rojas-Gómez D; González-Casanova J; Díaz-Vásquez W; Chacín M; Angarita Dávila L Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201807 [TBL] [Abstract][Full Text] [Related]
5. A survey of modulation of gut microbiota by dietary polyphenols. Dueñas M; Muñoz-González I; Cueva C; Jiménez-Girón A; Sánchez-Patán F; Santos-Buelga C; Moreno-Arribas MV; Bartolomé B Biomed Res Int; 2015; 2015():850902. PubMed ID: 25793210 [TBL] [Abstract][Full Text] [Related]
6. The gut microbiota as a novel regulator of cardiovascular function and disease. Battson ML; Lee DM; Weir TL; Gentile CL J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903 [TBL] [Abstract][Full Text] [Related]
7. The effects of grape and red wine polyphenols on gut microbiota - A systematic review. Nash V; Ranadheera CS; Georgousopoulou EN; Mellor DD; Panagiotakos DB; McKune AJ; Kellett J; Naumovski N Food Res Int; 2018 Nov; 113():277-287. PubMed ID: 30195522 [TBL] [Abstract][Full Text] [Related]
8. The Influence of Polyphenols on Atherosclerosis Development. Ziółkiewicz A; Kasprzak-Drozd K; Rusinek R; Markut-Miotła E; Oniszczuk A Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108307 [TBL] [Abstract][Full Text] [Related]
9. Microbe-bio-Chemical Insight: Reviewing Interactions between Dietary Polyphenols and Gut Microbiota. Mahajan R; Attri S; Mehta V; Udayabanu M; Goel G Mini Rev Med Chem; 2018; 18(15):1253-1264. PubMed ID: 27781961 [TBL] [Abstract][Full Text] [Related]
10. Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. Marín L; Miguélez EM; Villar CJ; Lombó F Biomed Res Int; 2015; 2015():905215. PubMed ID: 25802870 [TBL] [Abstract][Full Text] [Related]
11. The gut microbiome and cardiovascular disease: current knowledge and clinical potential. Ahmad AF; Dwivedi G; O'Gara F; Caparros-Martin J; Ward NC Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H923-H938. PubMed ID: 31469291 [TBL] [Abstract][Full Text] [Related]
12. The human gut microbiome - a new and exciting avenue in cardiovascular drug discovery. Du Y; Li X; Su C; Wang L; Jiang J; Hong B Expert Opin Drug Discov; 2019 Oct; 14(10):1037-1052. PubMed ID: 31315489 [No Abstract] [Full Text] [Related]
13. Interactions of gut microbiota with dietary polyphenols and consequences to human health. Tomás-Barberán FA; Selma MV; Espín JC Curr Opin Clin Nutr Metab Care; 2016 Nov; 19(6):471-476. PubMed ID: 27490306 [TBL] [Abstract][Full Text] [Related]
14. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity. Kasselman LJ; Vernice NA; DeLeon J; Reiss AB Atherosclerosis; 2018 Apr; 271():203-213. PubMed ID: 29524863 [TBL] [Abstract][Full Text] [Related]
15. The Role of Phytochemicals and Gut Microbiome in Atherosclerosis in Preclinical Mouse Models. Centner AM; Khalili L; Ukhanov V; Kadyan S; Nagpal R; Salazar G Nutrients; 2023 Feb; 15(5):. PubMed ID: 36904211 [TBL] [Abstract][Full Text] [Related]
16. Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk. Koopen AM; Groen AK; Nieuwdorp M Curr Opin Lipidol; 2016 Dec; 27(6):615-622. PubMed ID: 27676197 [TBL] [Abstract][Full Text] [Related]
17. The Role of Polyphenols in Regulation of Heat Shock Proteins and Gut Microbiota in Weaning Stress. Hussain T; Wang J; Murtaza G; Metwally E; Yang H; Kalhoro MS; Kalhoro DH; Rahu BA; Tan B; Sahito RGA; Chughtai MI; Yin Y Oxid Med Cell Longev; 2021; 2021():6676444. PubMed ID: 34531940 [TBL] [Abstract][Full Text] [Related]
18. Gut microbiome as a novel cardiovascular therapeutic target. Singh V; Yeoh BS; Vijay-Kumar M Curr Opin Pharmacol; 2016 Apr; 27():8-12. PubMed ID: 26828626 [TBL] [Abstract][Full Text] [Related]
19. Potential of dietary polyphenols for protection from age-related decline and neurodegeneration: a role for gut microbiota? Ross FC; Mayer DE; Horn J; Cryan JF; Del Rio D; Randolph E; Gill CIR; Gupta A; Ross RP; Stanton C; Mayer EA Nutr Neurosci; 2024 Sep; 27(9):1058-1076. PubMed ID: 38287652 [TBL] [Abstract][Full Text] [Related]
20. Polyphenols in the management of brain disorders: Modulation of the microbiota-gut-brain axis. Serra D; Almeida LM; Dinis TCP Adv Food Nutr Res; 2020; 91():1-27. PubMed ID: 32035595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]